Johnson & Johnson stock sinks back to 200-day moving average on third talc verdict

Johnson & Johnson stock sold off over 5% on Tuesday.
A Texas court stopped the company from allowing its talc subsidiary to file for bankruptcy.
This was the third time JNJ had attempted to conclude its talc lawsuits via bankruptcy court.
Reuters reports that pharma companies might get a gradual road toward 25% tariffs.

Clay Webster FXStreet

Johnson & Johnson (JNJ) stock dropped back to the 200-day Simple Moving Average (SMA) on Tuesday after the company’s attempt to place its former talc business in bankruptcy failed for the third time.

A judge in Texas dismissed the healthcare giant’s case to get rid of tens of thousands of lawsuits that claim Johnson & Johnson’s talc-based baby powder caused cancer. This means that the parent company will likely face financial claims separately at trial that could end up costing more than the $9 billion it has agreed to pay.

The US stock market rebounded in the late morning trade on Tuesday after shedding weight soon after the open. The Dow Jones Industrial Average (DJIA) has gained 0.25% at the time of writing, while the NASDAQ Composite is up 1.00%.

Johnson & Johnson stock news

Johnson & Johnson had created a subsidiary to own all of its talc assets called Red River Talc. It then agreed with 83% of claimants to file for bankruptcy and then fund the subsidiary with $9 billion to be divided up among claimants. This legal strategy is sometimes called a Texas Two-Step.

The 83% of “yes” votes is key since the law requires 75% of claimants to agree to this type of plan. However, US Bankruptcy Court Judge Christopher Lopez concluded that Johnson & Johnson had not given claimants enough time to decide on their vote.

The company’s attempt to have Red River Talc file for bankruptcy has already failed twice at a similar court in New Jersey.

"The decision to litigate every filed case is based on the simple fact that this is a fake claim created by greedy plaintiff lawyers looking for another deep pocket to sue and fueled by litigation-financed attorney advertising," J&J Worldwide Vice President of Litigation Erik Haas said in a statement.

In a good sign for the company, Reuters is reporting that pharmaceutical companies are likely to win a slight reprieve from the Trump administration. While the White House is expected to place 25% tariffs on the import of most foreign goods, sources tell Reuters that pharma companies will likely see tariffs rise gradually to 25% rather than facing a sudden cliff. This will allow pharma companies to reshore their production of precursors and active ingredients back to the United States over the next year.

Johnson & Johnson stock forecast

Johnson & Johnson stock broke through the 50-day SMA on Tuesday but halted before the 200-day SMA. This gives the 200-day more significance but also means that a break of that purple line will cause even heavier selling.

Further support lies at the recent lows from December and January between $140.50 and $142.50.

JNJ stock needs to overtake the former support level at $162.50 to remove itself from the technical downtrend.

JNJ daily stock chart

Author

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

GBP/USD hits multi-week tops around 1.3560

GBP/USD gathers fresh steam and advances to new three-month peaks near the 1.3560 zone on Friday. Cable’s sharp move higher comes after three daily drops in a row and follows the increasing selling pressure hurting the Greenback.

EUR/USD pops to fresh two-month highs, targets 1.1600

EUR/USD advances markedly, revisiting the upper 1.1500s for the first time since mid-June. The pair’s sharp uptick comes on the back of a strong retracement in the US Dollar amid BoJ intervention chatter and despite steady uncertainty in the Middle East.

Gold picks up pace, approaches $4,400

Gold rebounds toward the $4,400 mark per troy ounce on Friday, reversing the previous day’s pullback. The precious metal’s recovery comes as fresh and intense weakness keep weighing on the US Dollar, while traders keep assessing easing expectations of an imminent Fed interest rate hike and the situation from the Middle East.

Pi Network Price Forecast: PI extends consolidation as bulls eye $0.10

Pi Network (PI) price holds steady on Friday, maintaining a consolidating tone for three consecutive days. Mild retail strength in the PI token remains stable, with Open Interest above $9 million, while social buzz eases. PI token’s technical outlook is mixed, as bearish momentum wanes to neutral, with bulls eyeing the $0.1000 psychological level.

Weekly focus: Some relief in US inflation concerns

Actual inflation data for July came out as expected with a 0.1% m/m increase in headline CPI and 0.2% excluding food and energy. Annual headline inflation remains too high at 3.4% and means that wage earners are experiencing stagnating spending power at best, and core inflation is a bit higher than the inflation target of two percent would suggest.

Why is Crude Oil priced for a reopening the ships haven't made?

Fourteen vessels crossed the Strait of Hormuz on Tuesday. Before the war, the count ran near 120 a day. In the sessions since the waterway was publicly declared open, Brent has drifted back to $87 and West Texas Intermediate (WTI) to $81, both a little lower again on Wednesday, with daily momentum on each unwound from the top of its range in late July to the low twenties now.